1546 related articles for article (PubMed ID: 17903393)
21. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL
Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710
[TBL] [Abstract][Full Text] [Related]
22. Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study.
Pan PY; Lee MS; Lo MC; Yang EL; Yeh CB
BMC Psychiatry; 2014 May; 14():145. PubMed ID: 24885966
[TBL] [Abstract][Full Text] [Related]
23. Treatment of bipolar depression: making sensible decisions.
Citrome L
CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
Tohen M; Chengappa KN; Suppes T; Zarate CA; Calabrese JR; Bowden CL; Sachs GS; Kupfer DJ; Baker RW; Risser RC; Keeter EL; Feldman PD; Tollefson GD; Breier A
Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
[TBL] [Abstract][Full Text] [Related]
25. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J;
J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
[TBL] [Abstract][Full Text] [Related]
26. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
Maina G; Albert U; Salvi V; Mancini M; Bogetto F
J Affect Disord; 2007 Apr; 99(1-3):247-51. PubMed ID: 17056122
[TBL] [Abstract][Full Text] [Related]
27. Valproate for acute mood episodes in bipolar disorder.
Macritchie K; Geddes JR; Scott J; Haslam D; de Lima M; Goodwin G
Cochrane Database Syst Rev; 2003; (1):CD004052. PubMed ID: 12535506
[TBL] [Abstract][Full Text] [Related]
28. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.
Tohen M; Chengappa KN; Suppes T; Baker RW; Zarate CA; Bowden CL; Sachs GS; Kupfer DJ; Ghaemi SN; Feldman PD; Risser RC; Evans AR; Calabrese JR
Br J Psychiatry; 2004 Apr; 184():337-45. PubMed ID: 15056579
[TBL] [Abstract][Full Text] [Related]
29. Aripiprazole alone or in combination for acute mania.
Brown R; Taylor MJ; Geddes J
Cochrane Database Syst Rev; 2013 Dec; (12):CD005000. PubMed ID: 24346956
[TBL] [Abstract][Full Text] [Related]
30. Treating mixed mania/hypomania: a review and synthesis of the evidence.
Takeshima M
CNS Spectr; 2017 Apr; 22(2):177-185. PubMed ID: 28004626
[TBL] [Abstract][Full Text] [Related]
31. Valproate for acute mania.
Jochim J; Rifkin-Zybutz RP; Geddes J; Cipriani A
Cochrane Database Syst Rev; 2019 Oct; 10(10):CD004052. PubMed ID: 31621892
[TBL] [Abstract][Full Text] [Related]
32. Strategies for preventing the recurrence of bipolar disorder.
Ghaemi SN; Pardo TB; Hsu DJ
J Clin Psychiatry; 2004; 65 Suppl 10():16-23. PubMed ID: 15242328
[TBL] [Abstract][Full Text] [Related]
33. Acute and maintenance treatment with mood stabilizers.
Bowden CL
Int J Neuropsychopharmacol; 2003 Sep; 6(3):269-75. PubMed ID: 12974993
[TBL] [Abstract][Full Text] [Related]
34. Bipolar disorders.
McIntyre RS; Berk M; Brietzke E; Goldstein BI; López-Jaramillo C; Kessing LV; Malhi GS; Nierenberg AA; Rosenblat JD; Majeed A; Vieta E; Vinberg M; Young AH; Mansur RB
Lancet; 2020 Dec; 396(10265):1841-1856. PubMed ID: 33278937
[TBL] [Abstract][Full Text] [Related]
35. Newer treatment studies for bipolar depression.
Gao K; Calabrese JR
Bipolar Disord; 2005; 7 Suppl 5():13-23. PubMed ID: 16225556
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar I patients stratified by index manic or mixed episode.
Yatham LN; Fountoulakis KN; Rahman Z; Ammerman D; Fyans P; Marler SV; Baker RA; Carlson BX
J Affect Disord; 2013 May; 147(1-3):365-72. PubMed ID: 23290791
[TBL] [Abstract][Full Text] [Related]
37. Spotlight on olanzapine in bipolar I disorder.
McCormack PL; Wiseman LR
CNS Drugs; 2005; 19(6):553-5. PubMed ID: 15963003
[TBL] [Abstract][Full Text] [Related]
38. Olanzapine: a review of its use in the management of bipolar I disorder.
McCormack PL; Wiseman LR
Drugs; 2004; 64(23):2709-26. PubMed ID: 15537371
[TBL] [Abstract][Full Text] [Related]
39. Treatment of bipolar disorder: a systematic review of available data and clinical perspectives.
Fountoulakis KN; Vieta E
Int J Neuropsychopharmacol; 2008 Nov; 11(7):999-1029. PubMed ID: 18752718
[TBL] [Abstract][Full Text] [Related]
40. Valproate.
Bowden CL
Bipolar Disord; 2003 Jun; 5(3):189-202. PubMed ID: 12780873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
